• 제목/요약/키워드: Antitumor activity activity

검색결과 1,046건 처리시간 0.023초

Soluble Prokaryotic Expression and Purification of Bioactive Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand

  • Do, Bich Hang;Nguyen, Minh Tan;Song, Jung-A;Park, Sangsu;Yoo, Jiwon;Jang, Jaepyeong;Lee, Sunju;So, Seoungjun;Yoon, Yejin;Kim, Inki;Lee, Kyungjin;Jang, Yeon Jin;Choe, Han
    • Journal of Microbiology and Biotechnology
    • /
    • 제27권12호
    • /
    • pp.2156-2164
    • /
    • 2017
  • Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is considered as an antitumor agent owing to its ability to induce apoptosis of cancer cells without imparting toxicity toward most normal cells. TRAIL is produced in poor yield because of its insoluble expression in the cytoplasm of E. coli. In this study, we achieved soluble expression of TRAIL by fusing maltose-binding protein (MBP), b'a' domain of protein disulfide isomerase (PDIb'a'), or protein disulfide isomerase at the N-terminus of TRAIL. The TRAIL was purified using subsequent immobilized metal affinity chromatography and amylose-binding chromatography, with the tag removal using tobacco etch virus protease. Approximately 4.5 mg of pure TRAIL was produced from 125 ml flask culture with a purification yield of 71.6%. The endotoxin level of the final product was $0.4EU/{\mu}g$, as measured by the Limulus amebocyte lysate endotoxin assay. The purified TRAIL was validated and shown to cause apoptosis of HeLa cells with an $EC_{50}$ and Hill coefficient of $0.6{{\pm}}0.03nM$ and $2.41{\pm}0.15$, respectively. The high level of apoptosis in HeLa cells following administration of purified TRAIL indicates the significance and novelty of this method for producing high-grade and high-yield TRAIL.

인삼의 지용성 추출물 투여가 면역기능에 미치는 영향 (Effects of Lipid Soluble Ginseng Extract on Immune Response)

  • 김동청;황우익;인만진;이성동
    • Journal of Ginseng Research
    • /
    • 제32권1호
    • /
    • pp.19-25
    • /
    • 2008
  • 인삼의 지용성 성분을 2개월 및 6개월 동안 암환자에게 복용시킨 결과, 인삼의 지용성 성분은 CD4/CD8 비율과 자연살해세포의 수를 정상적으로 유지시킴으로써 암환자의 면역기능 유지에 효과가 있음을 보여주었다. 인삼의 지용성 성분을 2개월간 투여한 실험군의 87.5%에서, 6개월간 투여한 실험군의50%에서 암환자의 종양수치가 낮아지거나 정상범위에서 안정하게 유지되는 긍정적인 효과가 나타났다. 인삼의 지용성 성분을 6개월간 투여한 실험군에서 간 기능을 나타내는 GOT,GPT 및 ALP 수치와 신장 기능을 나타내는 BUN과 creatinine수치도 역시 정상 범위로 유지되어 인삼의 지용성 성분의 장기 복용이 간과 신장 기능에 긍정적인 효과를 가짐을 확인하였다. 따라서 인삼의 지용성 성분이 암환자들의 면역성 강화,간·신장 기능을 유지 및 개선시켜 건강에 도움을 주는 것으로 평가됨으로써 인삼의 지용성 성분을 암환자의 식이 및 항암보조제로서 적용할 수 있는 가능성을 제시하였다. 이러한결과는 비록 통계학적인 유의성은 없지만 본격적인 임상실험의 수행을 위한 기초 자료로서 충분한 가치를 가지므로, 이를바탕으로 대단위 개체를 대상으로 하는 본격적인 추가 임상실험 연구를 수행하여 인삼의 지용성 성분이 암환자의 항암및 면역기능 강화에 효과가 있음을 임상적으로 증명할 수 있을 것으로 기대한다.

유근피(楡根皮) 추출액(抽出液)이 HeoG2 간암세포(肝癌細胞)에 미치는 항암효과(抗癌效果) 및 기전(機轉)에 대(對)한 연구(硏究) (A Study on Antitumor Effect and Mechanism of Cortex ulmi pumilae Water Extract on HepG2 Hepatoma cell)

  • 최수덕;박용권;김강산;강병기;한상일
    • 대한한방내과학회지
    • /
    • 제21권2호
    • /
    • pp.259-266
    • /
    • 2000
  • Objectives : The effects of aqueous extracts of Cortex ulmi pumilae (a traditional medicine for cancer treatment in oriental medicine) on the induction of apoptotic cell death were investigated in human liver origm hepatoma cell lines, HepG2. Methods : The death of HepG2 cells was markedly induced by the addition of extracts of Cortex ulmi pumilae in a dose-dependent manner. The apoptotic characteristic ladder pattern of DNA strand break was not observed in cell death of HepG2. In addition, it was not shown nucleus chromatin condensation and fragmentation under hoechst staining. However, by the using annexin V staining assay, externalizations of phosphatidylserine in HepG2 cell which were treated with Cortex ulmi pumilae extracts were detected in the early time (at 9 hr after extract treatment). Furthermore, LDH release was not detected in this early stage. Therefore, Cortex ulmi pumilae extracts-induced cell death of HepG2 cells is mediated by apoptotic death signal processes. Result : The activity of caspase 3-like proteases remained in a basal level in HepG2 cells which treated with the extract of Cordyceps sinensis. However, it was markedly increased in HepG2 cells which treated with two extracts of Cortex ulmi pumilae (C.U.P.-C, C.U.P.-K) which were differently extracted (respectively, 2.3 and 3.3 fold). On a while, the phosphotransferase activities of JNK1 was markedly induced in HepG2 cells which were treated with two extracts of Cortex ulmi pumilae. On the contrary, the activation of transcriptional activator, activating protein1(AP-1) and NF-kB were severely decreased by these two extracts of Cortex ulmi pumilae (C.U.P.-C, C.U.P.-K). In addition, antioxidants (GSH and NAC) and intracellular $Ca2^+$ level regulator (Bapta/AM and Thapsigargin) did not affect Cortex ulmi pumilae extracts-induced apoptotic death of HepG2 cells. Conclusions : In conclusion, our results suggest that two extracts of Cortex ulmi pumilae (C.U.P.-C, C.U.P.-K) induces the apoptotic death of human liver origin hepatoma HepG2 cells via activation of caspase 3-like proteases as well as JNK1, and inhibition of transcriptional activators, AP-1 and $NK-{\kappa}B$.

  • PDF

A New Histone Deacetylase Inhibitor, MHY4381, Induces Apoptosis via Generation of Reactive Oxygen Species in Human Prostate Cancer Cells

  • Richa, Sachan;Dey, Prasanta;Park, Chaeun;Yang, Jungho;Son, Ji Yeon;Park, Jae Hyeon;Lee, Su Hyun;Ahn, Mee-Young;Kim, In Su;Moon, Hyung Ryong;Kim, Hyung Sik
    • Biomolecules & Therapeutics
    • /
    • 제28권2호
    • /
    • pp.184-194
    • /
    • 2020
  • Histone deacetylase (HDAC) inhibitors represent a novel class of anticancer agents, which can be used to inhibit cell proliferation and induce apoptosis in several types of cancer cells. In this study, we investigated the anticancer activity of MHY4381, a newly synthesized HDAC inhibitor, against human prostate cancer cell lines and compared its efficacy with that of suberoylanilide hydroxamic acid (SAHA), a well-known HDAC inhibitor. We assessed cell viability, apoptosis, cell cycle regulation, and other biological effects in the prostate cancer cells. We also evaluated a possible mechanism of MHY4381 on the apoptotic cell death pathway. The IC50 value of MHY4381 was lower in DU145 cells (IC50=0.31 µM) than in LNCaP (IC50=0.85 µM) and PC-3 cells (IC50=5.23 µM). In addition, the IC50 values of MHY4381 measured in this assay were significantly lower than those of SAHA against prostate cancer cell lines. MHY4381 increased the levels of acetylated histones H3 and H4 and reduced the expression of HDAC proteins in the prostate cancer cell lines. MHY4381 increased G2/M phase arrest in DU145 cells, and G1 arrest in LNCaP cells. It also activated reactive oxygen species (ROS) generation, which induced apoptosis in the DU145 and LNCaP cells by increasing the ratio of Bax/Bcl-2 and releasing cytochrome c into the cytoplasm. Our results indicated that MHY4381 preferentially results in antitumor effects in DU145 and LNCaP cells via mitochondria-mediated apoptosis and ROS-facilitated cell death pathway, and therefore can be used as a promising prostate cancer therapeutic.

A549 인체폐암세포의 증식에 미치는 신령버섯 추출물의 영향에 관한 연구 (Anti-proliferative Effects of Water Extract of Agaricus blazei Murill in Human Lung Cancer Cell Line A549)

  • 최우영;박철;이재윤;김기영;박영민;정영기;이원호;최영현
    • 한국식품영양과학회지
    • /
    • 제33권8호
    • /
    • pp.1237-1245
    • /
    • 2004
  • 브라질 기원인 신령 버섯 (A. blazei murill)은 강력한 항암 및 면역강화 작용을 가진 것으로 알려져 있다. 본 연구에서는 신령버섯 수용성 추출물(water extracted A. blazei Murill, WEAB)이 A549 인체 폐암세포 증식에 미치는 영향을 조사하였으며, 증식억제와 연관된 기전 해석을 시도하였다. WEAB가 처리된 A549 세포는 처리 농도 의존적으로 생존율이 감소되었으며, WEAB 처리는 암세포의 다양한 형태적 변형을 유발하였다. Flow cytometry 분석 결과로서 WEAB 처리에 의한 A549 폐암세포의 증식억제는 세포주기 G2/M arrest 및 apoptosis 유발과 직접적으로 연관성이 있음을 알 수 있었다. WEAB가 처리된 암세포에서 전사 및 번역 수준에서 cyclin A 발현의 감소 및 Cdk inhibitor p21 발현의 증가 현상이 관찰되었으나, cyclin B1, Cdk2, Cdc2, Wee1, Cdc25c 및 p53 등의 발현에는 큰 변화가 관찰되지 못하였다. 또한 WEAB의 처리는 COX-2 선택적 발현 저하를 유발하였으나, telomere 조절 관련 유전자들의 발현에는 큰 영향을 주지 못하였다. 이상의 결과는 신령버섯 추출물이 강력한 항암 및 암 예방 효능의 잠재력을 가지고 있음을 의미하며, 이에 관한 지속적인 연구가 필요할 것으로 생각된다.

천연물을 이용한 담자균의 균사체 배양 (Liquid Culture of Basidiomycetes on Natural Media)

  • 김선희;이종숙;박경숙;이재성;이항우;박신
    • 한국균학회지
    • /
    • 제27권6호
    • /
    • pp.373-377
    • /
    • 1999
  • 천연배지를 이용하여 담자균을 배양시킨 후 간단한 가공 공정을 거처 식이 가능한 기능성 음료를 개발하고자 대추추출액을 이용하여 균사체 배양조건을 확립하였다. Ganoderma lucidum의 경우 대추 추출액을 이용한 액체 배지의 최적 배양 당도와 pH는 5 Brix, pH 4이었으며, 균사체가 생장하는 데에 있어서 최적배양기간은 균사체 건물량, 색도의 변화를 조사한 결과 배양 10일째로 나타났다. Coriolus versicolor의 경우 최적 배양 당도와 pH는 5 Brix, pH 5이었으며, 최적배양기간은 10일이었다. Phellinus igniarius의 경우 최적 배양 당도와 pH는 5 Brix, pH 5이었으며, 최적 배양기간은 18일이었다. 항암 실험을 실시한 결과, Phellinus igniarius와 Ganoderma lucidum 배양액이 대추 추출액에 비하여 위암세포(Human stomach adenocarcinoma cell lines) 억제효과가 4배나 되었으며 백혈병 세포(Leukemic cell lines)억제 효과는 2배가 되었다.

  • PDF

누에 나방에 있어서 한국산 겨우살이(Viscum album coloratum) 추출물의 생명연장 효과 (Effect of Korean Mistletoe (Viscum album coloratum) Extract (KME) on the Extensions of Life span in Silkworm Moth, Bombyx Mori)

  • 정회윤;이안나;김세중;박성민;송태준;고병웅;김영훈;안효선;유영춘;민병렬;김종배
    • 생약학회지
    • /
    • 제39권4호
    • /
    • pp.310-315
    • /
    • 2008
  • Viscum album coloratum (Korean mistletoe; KM) is a semi-parasitic plant growing on various trees. This plant hasbeen shown to possess a variety of biological functions such as immunomodulation, apoptosis-induction and antitumor activity. However, there is no information about how the extract of KM affects life span of the host. In this study, in order to examine the effect of KM on the longevity of the host, we investigated whether a Korean mistletoe extract (KME) was able to extend the life length in an experimental model using the spring silkworm moth of Bombyx mori (Lepidoptera bombycidae). We established a model test for survival in which all of the male and female moths died within 18 days after the beginning of the experiment. Mean survival time of female moths was longer than that of male moths. Both male and female moths fed with KME containing diet (200 or 400 ${\mu}g$/head/day) showed significantly higher mean survival times than those of the control moths. Studying the effect of KME on prolongation of mean survival time showed that male moths were more susceptible than female moths. The moths fed with KME-containing diet showed a slight decrease in body weight. Interestingly, however, no difference in food intake was observed between moths fed with KME-containing diet and those with control diet. In analysis for mRNA increase in the SIRT2 gene, a member of the Sir2 gene family playing important roles in regulation of cell death and prolongation of life span, moths fed with KME-containing diet showed a significant increase in SIRT2 gene expression. These results suggest that KME has a potential to extend the life span in Bombyx mori, and its effect is partly associated with increase in SIRT2 gene expression.

상기생과 봉독이 간암 세포주 Hep G2에 대해 미치는 항암 기전 비교 (Comparative Study of Korean Mistletoe Lectin and Bee Venom on the Anti-Cancer Effect and Its Mechanisms of Action in Hepatocellular Carcinoma Cells)

  • 김승욱;김보람;허경;임성우
    • 대한한방내과학회지
    • /
    • 제30권4호
    • /
    • pp.845-857
    • /
    • 2009
  • Background and Objectives : Korean mistletoe lectin (Viscum album coloratum agglutinin, VCA) and bee venom (BV) have been reported to induce apoptosis in various cancer cell lines in vitro and to show antitumor activity against a variety of tumors in animal models. However, the comparative effect of VCA and BV on the anti-cancer effect and mechanisms of action has not been determined. In this study, the effect in a human hepatocellular carcinoma cell line, Hep G2 cells, was examined. Methods : Cytotoxic effects of VCA and BV on Hep G2 cells were determined by 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) assay in litro. The apoptotic cell death was then confirmed by propidium iodide staining and DNA fragmentation analysis. The mechanisms of action were examined by the expression of anti-apoptotic proteins and activation of mitogen-activated protein kinases. The involvement of kinase was examined in VCA or BV-induced apoptosis by using kinase inhibitors. Results : VCA and BV killed Hep G2 cells in a time and dose-dependent manner. Treatment of Hep G2 cells with VCA activated poly (ADP-ribose) polymerase-1 (PARP-1) known as a marker of apoptosis, and mitogen-activated protein kinases signaling pathways including MAPK/ERK, p38 MAPK and JNK. BV also activated PARP-1, MAPK/ERK. and p38 MAPK but not JNK. The expression level of anti-apoptotic molecule, Bcl-X, was decreased by VCA treatment but not by BV. Finally, the phosphorylation level of ERM proteins involved in the cytoskeleton homeostasis was decreased by both stimuli. VCA-induced apoptosis was partially inhibited by in the presence of JNK and p38 inhibitor, but BV only by p38 inhibitor. Conclusions : VCA-induced apoptosis is dependent on the activation of p38 and JNK. while BV-induced apoptosis is mediated by p38 activation in Hep G2 cells.

  • PDF

Bauhinia forficata 추출물의 인체 암세포에 대한 성장억제 및 세포사멸 유도 활성 (Antiproliferative Effect and Apoptotic Induction of Bauhinia forficata Extract in Human Cancer Cells.)

  • 임혜영;이철훈
    • 한국미생물·생명공학회지
    • /
    • 제32권1호
    • /
    • pp.67-71
    • /
    • 2004
  • 남미 아마존 유역의 열대 우림 자생식물인 Pata de Vaca(Bauhinia forficata)의 추출물로부터 활성분획을 분리하여, 세포성장 억제활성 및 세포사멸 유도에 관해 조사하였다. MTT assay를 통해 그 저해 활성을 비교 분석해 가면서 Pata de Vaca의 70% ethanol 추출물을 HP-20 Diaion column chromatograph 및 C-18 column chromatography에 순차적으로 적용시켰다. 그 결과, 저해 활성이 가장 강하며 수율이 높은 Pata-50을 분리하여, 6종의 암세포주에 대한 MTT assay를 실시하였다. Pata-50에 의한 세포성장 억제는, MCF-7을 제외한 나머지 세포주인 HepG2, HT-29, AGS, A549 및 HeLa세포에 대해서 농도 의존적인 저해활성을 보였으며, $IC_{50}$ 는 40.4-77.5$\mu\textrm{g}$/$m\ell$의 농도 범위에서 나타났다. Pata-50의 세포성장 억제를 확인하였으므로, HepG2 세포에.If Pata-50에 의한 세포주기의 변화와 세포사별로 유도되는 세포의 분포를 측정하기 위하여 flow cytometry analysis를 실시하였다. 그 결과, Pata-50은 HepG2에 대하여 농도 의존적으로 세포사멸을 유도하지만, 세포주기 조절에는 아무런 영향을 미치지 많고 있음을 알 수 있었다. 특히, Pata-50을 50$\mu\textrm{g}$/$m\ell$ 이하로 처리할 경우에는 apoptosis가 유도된 세포기 비율이 10%미만이지만, 80$\mu\textrm{g}$/$m\ell$ 및 110$\mu\textrm{g}$/$m\ell$을 처리하면 28.6%및 56.2%로_급격히 증가하였다. 다음으로, 세사멸에 결정적인 단백질의 발현 양상을 관찰하기 위해, HeLa세포주에 Pata-50을 농도별로 처리하여 Western blot으로 분석하였다. Fig. 4에 나타난 바와 같이, HeLa 세포주에 Pata-50을 80$\mu\textrm{g}$/$m\ell$의 농도로 처리하였을 때, caspase-3.가 활성화되었으며, 이로 인해, PARP가 116 kDa에서 85kDa로 cleavag되어, 불활성화 되는 것을 확인할 수 있었다.

Comparative Analysis of the Efficacy and Safety of Oxaliplatin Plus 5-Fluorouracil/Leucovorin (Modified FOLFOX6) with Advanced Gastric Cancer Patients having a Good or Poor Performance Status

  • Hacibekiroglu, Ilhan;Kodaz, Hilmi;Erdogan, Bulent;Turkmen, Esma;Esenkaya, Asim;Uzunoglu, Sernaz;Cicin, Irfan
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제16권6호
    • /
    • pp.2355-2359
    • /
    • 2015
  • Background: Combination chemotherapy of 5 fluorouracil (5-FU) and leucovorin (LV) with oxaliplatin, mainly FOLFOX regimens, has shown considerable antitumor activity and a tolerable toxicity profile in gastric cancer. The goal of this study was to retrospectively compare the efficacy and toxicity of modified FOLFOX-6 (mFOLFOX6) regimen in advanced gastric cancer (AGC) patients with good and poor performance status (PS). Materials and Methods: AGC patients receiving the mFOLFOX6 regimen including oxaliplatin $85mg/m^2$, bolus of 5-FU $400mg/m^2$ and LV $400mg/m^2$ on the first day, followed by $2400mg/m^2$ of 5- FU as a continious infusion over 46 hour for first-line treatment were eligible for the study. Results: A total 58 patients with a median age of 59.5 (32-81) were included. The median follow up of the study was 9.2 months. Thirty patients (51.7%) with an ECOG PS 0-1 were assigned to the good PS arm, while 28 patients (48.3%) with ECOG PS 2 were in the poor PS arm. Overall response rates were 36.6 and 28.8%, respectively (p=0.91). Median PFS was 6.7 and 6.3 months in good PS and poor PS arms (p=0.50) and median OS was 9.6 and 10.4 months (p=0.55). As compared with good PS arm, poor PS arm was associated with more grade 3-4 neutropenia and anemia. Dose reduction and dose delays were also significantly higher. Conclusions: In this study, mFOLFOX6 was similarly effective in both arms. Although hematologic toxicity was significantly higher in patients with poor PS, it remained manageable. Our results suggest that this regimen may be an effective treatment option for AGC patients with poor PS.